InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Thursday, 04/19/2012 8:07:09 AM

Thursday, April 19, 2012 8:07:09 AM

Post# of 636
Human Genome surges 99% after rejecting GSK bid. Human Genome Sciences (HGSI) has turned down an unsolicited offer of $13 a share from GlaxoSmithKline (GSK) as undervaluing the company. However Human Genome said it's exploring "strategic alternatives," including a sale, and has invited GSK to take part in the process. HGSI closed at $7.17 yesterday with a market cap of $1.4B. Human Genome's shares rocketed 99% to $14.30 premarket.
_____________________________________________________
http://seekingalpha.com/article/509431-wall-street-breakfast-must-know-news

HGSI